Kodak Shifts Into Drug Production With Help of $765 Million U.S. Loan

Date Published07/28/2020
Author Namerachel levy
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Kodak
Type of work Manufacturing
If manufacturing, is the company an OEM? Yes
Reshoring category:Reshoring
Total number of jobs (added or to be added):300
Year reshoring announced:2020
Domestically, the work will be done:In-house
Capital investment ($):765
Country(ies) from which reshored:China,India
City reshored to:Rochester
State(s) reshored to:NY
If relevant, work nearshored to:-
Product(s) reshoredingredients for generic drugs, hydroxychloroquine
What non-domestic negative factors made offshoring less attractive?Green considerations, Supply chain interruption risk/Natural disaster risk/Political instability
What domestic positive factors made reshoring more attractive?Government Incentives, Impact on domestic economy, essential product supply, covid
Government Incentive dollar amount:765
Find Reshoring Articles